Patents by Inventor Prerna Bhargava

Prerna Bhargava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Specific antigen sequences for COVID-19 and methods of use
    Patent number: 11940449
    Abstract: Compositions and methods for immunological detection of coronavirus antibodies are provided.
    Type: Grant
    Filed: February 11, 2022
    Date of Patent: March 26, 2024
    Assignee: ID-Fish Technology, Inc.
    Inventors: Jyotsna S. Shah, Song Liu, Hari-Hara Potula, Prerna Bhargava
  • DIAGNOSIS OF BABESIA USING BABESIA RECOMBINANT PROTEINS
    Publication number: 20220341928
    Abstract: The disclosure, in some aspects, provides a composition comprising labelled and/or tagged and/or bound amino acid sequences useful for the detection of Babesia species. Also disclosed are methods for the detection of infection by one or more Babesia species.
    Type: Application
    Filed: April 22, 2022
    Publication date: October 27, 2022
    Applicant: ID-Fish Technology, Inc.
    Inventors: Jyotsna S. Shah, Olivia Mark, Song Liu, Prerna Bhargava, Hari-Hara Potula
  • SPECIFIC ANTIGEN SEQUENCES FOR COVID-19 AND METHODS OF USE
    Publication number: 20220260586
    Abstract: Compositions and methods for immunological detection of coronavirus antibodies are provided.
    Type: Application
    Filed: February 11, 2022
    Publication date: August 18, 2022
    Applicant: ID-Fish Technology, Inc.
    Inventors: Jyotsna S. Shah, Song Liu, Hari-Hara Potula, Prerna Bhargava
  • PREVENTION AND TREATMENT OF RESPIRATORY INFECTION WITH PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR DELTA AGONIST
    Publication number: 20150018396
    Abstract: The present disclosure is related generally to a method for prevention and/or treatment of infections, e.g., respiratory infections, in a subject before or after the onset of a disease state associated with the infection.
    Type: Application
    Filed: March 3, 2013
    Publication date: January 15, 2015
    Inventors: Chih-Hao Lee, Prerna Bhargava
  • METHODS OF TREATING FATTY LIVER DISEASE WITH HELMINTH-DERIVED GLYCAN-CONTAINING COMPOUNDS
    Publication number: 20140315781
    Abstract: The present invention provides a compound comprising a helminth-derived glycan and/or glycoconjugate thereof (e.g., a compound comprising a Lewisx antigen (e.g., LNFPIII), a non-Lewisx antigen (e.g., LNnT, LDN, and LDN derivatives), or a mixture of Lewisx and non-Lewisx antigens (e.g., SEA)), useful as a therapeutic compound for treating or preventing diseases associated with fat accumulation in the liver. The compounds of the invention are useful for treating or preventing the development of a fatty liver disease in a subject that has the disease or is at risk of developing the disease, and inhibiting lipogenesis in hepatocytes. The invention also provides methods of regulating the Erk-c-fos/AP-1-FXR? signalling pathway by administering a compound comprising a helminth-derived glycan and/or glycoconjugate thereof to a subject with a fatty liver disease, or contacting a hepatocyte with a compound comprising a helminth-derived glycan and/or glycoconjugate thereof.
    Type: Application
    Filed: September 21, 2012
    Publication date: October 23, 2014
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Chih-hao Lee, Prerna Bhargava, Donald A. Harn